Emilie Aschenbrenner, PharmD, BCOP, discusses how integrating CD38-targeted therapies into first-line treatment for transplant-ineligible multiple myeloma requires balancing clinical benefit, cost, ...

High stigma due to HIV was also associated with depression and drug use, making the reduction in stigma vital for improving the care of women with HIV.